Literature DB >> 8313938

Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats.

L Garofalo1, A C Cuello.   

Abstract

This study examined the behavioral effects of maximal doses of exogenous NGF and/or GM1 when given intracerebroventricularly to adult rats with unilateral cortical lesions. In addition, the long-term effects of these agents on choline acetyltransferase (ChAT), glutamic acid decarboxylase (GAD) activity, and choline uptake, as well as on ChAT and NGF receptor (p75NGFR) immunoreactivity in various brain regions, were also investigated. When retested in passive avoidance and Morris water maze tasks, 30 days postlesion (i.e., 2 weeks after termination of treatment), decorticated vehicle-treated rats showed retention and reacquisition deficits which were equally attenuated by NGF (6 micrograms/day, 14 days) or NGF + GM1 (750 micrograms/day, 14 days) treatment. By contrast, lesioned animals which received GM1 alone only showed improved reacquisition of the two tasks. After behavioral testing (52 days postlesion) lesioned vehicle-treated animals had decreased ChAT activity in the ipsilateral nucleus basalis magnocellularis (NBM) but not in other subcortical brain areas examined. Neuronal loss was observed only in the ventrolateral nucleus of the ipsilateral dorsal thalamus. However, using quantitative image analysis a significant shrinkage of ChAT immunoreactive (IR) and p75NGFR-IR NBM neurons as well as a decrease in their neuritic network was noted, particularly in the mid portion of the NBM. GM1 and NGF equally prevented these deficits in the NBM and, furthermore, enhanced ChAT activity and choline uptake in the remaining cortex ipsilateral to the lesion site. These alterations in NBM and cortical cholinergic markers were even more augmented in rats which received both NGF and GM1 treatment. By contrast, the noted NGF-induced increase in striatal ChAT activity was not further increased by concomitant GM1 treatment. GAD activity in all brain areas examined was unaltered by the lesion or any of the treatments and the apparent thalamic neuronal retrograde degeneration was not prevented by any of the treatments. It is concluded that GM1 or NGF treatment can distinctly affect performance of cortically lesioned rats in passive avoidance and Morris water maze tasks despite their equal ability to serve as long-term neuroprotective agents for the basalo-cortical cholinergic pathway.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8313938     DOI: 10.1006/exnr.1994.1024

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  9 in total

Review 1.  Gangliosides, NGF, brain aging and disease: a mini-review with personal reflections.

Authors:  A Claudio Cuello
Journal:  Neurochem Res       Date:  2012-04-08       Impact factor: 3.996

2.  Effects of basic fibroblast growth factor and ganglioside GM1 on neuronal survival in primary cultures and on eight-arm radial maze task in adult rats following partial fimbria transections.

Authors:  A Iwashita; H Hisajima; Y Notsu; M Okuhara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

Review 3.  Experimental neurotrophic factor therapy leads to cortical synaptic remodeling and compensates for behavioral deficits.

Authors:  A C Cuello
Journal:  J Psychiatry Neurosci       Date:  1997-01       Impact factor: 6.186

4.  A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat.

Authors:  T Debeir; H U Saragovi; A C Cuello
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

5.  Cortical hypometabolism in injured brain: new correlations with the noradrenergic and serotonergic systems and with behavioral deficits.

Authors:  H M Pappius
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

6.  Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes.

Authors:  T P Wong; T Debeir; K Duff; A C Cuello
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

7.  GM1 stabilizes expression of NMDA receptor subunit 1 in the ischemic hemisphere of MCAo/reperfusion rat.

Authors:  Jian-ren Liu; Mei-ping Ding; Er-qing Wei; Jian-hong Luo; Ying Song; Jian-zheng Huang; Qiu-fu Ge; Hua Hu; Li-jun Zhu
Journal:  J Zhejiang Univ Sci B       Date:  2005-04       Impact factor: 3.066

8.  LIGA20, a lyso derivative of ganglioside GM1, given orally after cortical thrombosis reduces infarct size and associated cognition deficit.

Authors:  A Kharlamov; I Zivkovic; A Polo; D M Armstrong; E Costa; A Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

Review 9.  Topical delivery of nerve growth factor for treatment of ocular and brain disorders.

Authors:  Gemma Eftimiadi; Marzia Soligo; Luigi Manni; Daniela Di Giuda; Maria Lucia Calcagni; Antonio Chiaretti
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.